$ECOR The purpose of this section of the website is to educate to U.S. payers, formulary committees, or other similar entities with knowledge and expertise in the area of health care economic analysis (collectively referred to as payors) on the economic burden of episodic cluster headache and health economic information relevant to value-based considerations regarding treatment in the United States. This section is not intended for healthcare providers making individual patient prescribing decisions or consumers. The information herein includes publications from third-party sources that were funded and approved by electroCore, as well as publications authored by electroCore employees. Please see individual articles for more detailed author disclosures. These publications are not necessarily reflective of real-world experience or the result of controlled clinical trials. electroCore makes no claims or recommendations regarding reimbursement or coverage for any products or services, including information about coding, charges or modifiers.
Recent ECOR News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 04/15/2026 08:05:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 08:05:06 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 08:01:02 PM
- electroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD • GlobeNewswire Inc. • 04/07/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 08:01:05 PM
- electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD • GlobeNewswire Inc. • 04/01/2026 12:00:00 PM
- electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/31/2026 12:00:00 PM
- electroCore Expands Intellectual Property Portfolio • GlobeNewswire Inc. • 03/30/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 10:01:50 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/19/2026 09:22:57 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/19/2026 08:35:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 08:10:30 PM
- electroCore Announces Full Year 2025 Financial Results and Organizational Changes • GlobeNewswire Inc. • 03/19/2026 08:05:00 PM
- electroCore to Participate at the 38th Annual Roth Conference • GlobeNewswire Inc. • 03/10/2026 12:00:00 PM
- electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026 • GlobeNewswire Inc. • 03/09/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 09:30:06 PM
- Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore’s gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder (“PTSD”) • GlobeNewswire Inc. • 01/21/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 09:05:52 PM
- electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million • GlobeNewswire Inc. • 01/20/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:15:45 PM
- TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen • GlobeNewswire Inc. • 12/02/2025 01:00:00 PM
- electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum • GlobeNewswire Inc. • 11/10/2025 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/05/2025 09:26:07 PM
